John P. Butler - Net Worth and Insider Trading

John P. Butler Net Worth

The estimated net worth of John P. Butler is at least $3 Million dollars as of 2024-04-28. John P. Butler is the CEO and President of Akebia Therapeutics Inc and owns about 2,364,436 shares of Akebia Therapeutics Inc (AKBA) stock worth over $3 Million. John P. Butler is the Director of Zynerba Pharmaceuticals Inc and owns about 80,765 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $104,995. John P. Butler is also the Director of Relypsa Inc and owns about 2,849 shares of Relypsa Inc (RLYP) stock worth over $91,140. Details can be seen in John P. Butler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John P. Butler has not made any transactions after 2024-02-29 and currently still holds the listed stock(s).

Transaction Summary of John P. Butler

To

John P. Butler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John P. Butler owns 4 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) , Akebia Therapeutics Inc (AKBA) , and Keryx Biopharmaceuticals Inc (KERX) among others .

Click here to see the complete history of John P. Butler’s form 4 insider trades.

Insider Ownership Summary of John P. Butler

Ticker Comapny Transaction Date Type of Owner
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 director
AKBA Akebia Therapeutics Inc 2024-02-29 director & CEO & President
KERX Keryx Biopharmaceuticals Inc 2017-06-09 director
RLYP Relypsa Inc 2016-09-01 director

John P. Butler Latest Holdings Summary

John P. Butler currently owns a total of 3 stocks. Among these stocks, John P. Butler owns 2,364,436 shares of Akebia Therapeutics Inc (AKBA) as of February 29, 2024, with a value of $3 Million and a weighting of 94.17%. John P. Butler owns 80,765 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of June 14, 2023, with a value of $104,995 and a weighting of 3.12%. John P. Butler also owns 2,849 shares of Relypsa Inc (RLYP) as of June 7, 2016, with a value of $91,140 and a weighting of 2.71%.

Latest Holdings of John P. Butler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKBA Akebia Therapeutics Inc 2024-02-29 2,364,436 1.34 3,168,344
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 80,765 1.30 104,995
RLYP Relypsa Inc 2016-06-07 2,849 31.99 91,140

Holding Weightings of John P. Butler


John P. Butler Form 4 Trading Tracker

According to the SEC Form 4 filings, John P. Butler has made a total of 6 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 46,570 shares on February 29, 2024, which brought John P. Butler around $73,581.

According to the SEC Form 4 filings, John P. Butler has made a total of 2 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 115 shares on June 14, 2023, which brought John P. Butler around $40.

According to the SEC Form 4 filings, John P. Butler has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the sale of 1,013 shares on June 7, 2016, which brought John P. Butler around $19,571.

Insider Trading History of John P. Butler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John P. Butler Trading Performance

GuruFocus tracks the stock performance after each of John P. Butler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John P. Butler is 93.47%. GuruFocus also compares John P. Butler's trading performance to market benchmark return within the same time period. The performance of stocks bought by John P. Butler within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John P. Butler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John P. Butler

Average Return

33.63%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 60.17 93.47 130.12 33.63 -15.79 -36.57
Relative Return to S&P 500(%) 57.17 92.91 133.53 25.36 -31.74 -48.7

John P. Butler Ownership Network

Ownership Network List of John P. Butler

No Data

Ownership Network Relation of John P. Butler


John P. Butler Owned Company Details

What does Zynerba Pharmaceuticals Inc do?

Who are the key executives at Zynerba Pharmaceuticals Inc?

John P. Butler is the director of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and President Terri B Sebree .

Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary

Over the past 18 months, John P. Butler made 1 insider transaction in Zynerba Pharmaceuticals Inc (ZYNE) with a net sale of 115. Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 53,283 shares made by Armando Anido , a net sale of 37,062 shares made by Terri B Sebree , and a net sale of 26,767 shares made by James E Fickenscher .

In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 139,381 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 139,381 shares.

Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zynerba Pharmaceuticals Inc Insider Transactions

No Available Data

John P. Butler Mailing Address

Above is the net worth, insider trading, and ownership report for John P. Butler. You might contact John P. Butler via mailing address: C/o Relypsa, Inc., 700 Saginaw Dr., Redwood City Ca 94063.

Discussions on John P. Butler

No discussions yet.